These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26064071)

  • 41. Incidence and risk factors of loss to follow-up among HIV-infected children in an antiretroviral treatment program.
    Kawilapat S; Salvadori N; Ngo-Giang-Huong N; Decker L; Kanjanavanit S; Puangsombat A; Preedisripipat K; Lertpienthum N; Akarathum N; Mekmullica J; Srirompotong U; Lallemant M; Le Coeur S; Traisathit P; Leroi C; Jourdain G
    PLoS One; 2019; 14(9):e0222082. PubMed ID: 31527875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu, Kenya.
    Ojwang' VO; Penner J; Blat C; Agot K; Bukusi EA; Cohen CR
    AIDS Care; 2016; 28(4):500-7. PubMed ID: 26565428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High rates of retention and viral suppression in the scale-up of antiretroviral therapy adherence clubs in Cape Town, South Africa.
    Tsondai PR; Wilkinson LS; Grimsrud A; Mdlalo PT; Ullauri A; Boulle A
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21649. PubMed ID: 28770595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term loss to follow-up in the TREAT Asia HIV Observational Database (TAHOD).
    Jiamsakul A; Kiertiburanakul S; Ng OT; Chaiwarith R; Wong W; Ditangco R; Nguyen KV; Avihingsanon A; Pujari S; Do CD; Lee MP; Ly PS; Yunihastuti E; Kumarasamy N; Kamarulzaman A; Tanuma J; Zhang F; Choi JY; Kantipong P; Sim B; Ross J; Law M; Merati TP;
    HIV Med; 2019 Aug; 20(7):439-449. PubMed ID: 30980495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of loss to follow up among patients with type 2 diabetes mellitus attending a private not for profit urban diabetes clinic in Uganda - a descriptive retrospective study.
    Tino S; Wekesa C; Kamacooko O; Makhoba A; Mwebaze R; Bengo S; Nabwato R; Kigongo A; Ddumba E; Mayanja BN; Kaleebu P; Newton R; Nyerinda M
    BMC Health Serv Res; 2019 Aug; 19(1):598. PubMed ID: 31443649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retention in care among HIV-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in Uganda: A retrospective cohort study.
    Muhumuza S; Akello E; Kyomugisha-Nuwagaba C; Baryamutuma R; Sebuliba I; Lutalo IM; Kansiime E; Kisaakye LN; Kiragga AN; King R; Bazeyo W; Lindan C
    PLoS One; 2017; 12(12):e0187605. PubMed ID: 29272268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retention in Care of Adult HIV Patients Initiating Antiretroviral Therapy in Tigray, Ethiopia: A Prospective Observational Cohort Study.
    Bucciardini R; Fragola V; Abegaz T; Lucattini S; Halifom A; Tadesse E; Berhe M; Pugliese K; Binelli A; De Castro P; Terlizzi R; Fucili L; Di Gregorio M; Mirra M; Olivieri E; Teklu T; Zegeye T; Haile A; Vella S; Abraham L; Godefay H;
    PLoS One; 2015; 10(9):e0136117. PubMed ID: 26340271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment outcomes and their determinants in HIV patients on Anti-retroviral Treatment Program in selected health facilities of Kembata and Hadiya zones, Southern Nations, Nationalities and Peoples Region, Ethiopia.
    Ayele W; Mulugeta A; Desta A; Rabito FA
    BMC Public Health; 2015 Aug; 15():826. PubMed ID: 26310943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study.
    Hønge BL; Jespersen S; Nordentoft PB; Medina C; da Silva D; da Silva ZJ; Ostergaard L; Laursen AL; Wejse C;
    BMJ Open; 2013 Oct; 3(10):e003499. PubMed ID: 24163204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High variability in tuberculosis treatment outcomes across 15 health facilities in a semi-urban area in central Ethiopia.
    Zenatti G; Raviglione M; Tesfaye F; Bobosha K; Björkman P; Walles J
    J Clin Tuberc Other Mycobact Dis; 2023 Feb; 30():100344. PubMed ID: 36578805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time-Dependent Predictors of Loss to Follow-Up in a Large HIV Treatment Cohort in Nigeria.
    Meloni ST; Chang C; Chaplin B; Rawizza H; Jolayemi O; Banigbe B; Okonkwo P; Kanki P
    Open Forum Infect Dis; 2014 Sep; 1(2):ofu055. PubMed ID: 25734125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does time to loss to follow-up differ among adult tuberculosis patients initiated on tuberculosis treatment and care between general hospital and health centers? A retrospective cohort study.
    Shaweno T; Getnet M; Fikru C
    Trop Med Health; 2020; 48():9. PubMed ID: 32099523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment Outcomes Among Older Human Immunodeficiency Virus-Infected Adults in Nigeria.
    Agaba PA; Meloni ST; Sule HM; Agbaji OO; Sagay AS; Okonkwo P; Idoko JA; Kanki PJ
    Open Forum Infect Dis; 2017; 4(2):ofx031. PubMed ID: 29497627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss to follow-up among children in pre-ART care under the National AIDS Programme, Tamil Nadu, South India.
    Devi NP; Kumar AMV; Chinnakali P; Rajendran M; Valan AS; Rewari BB; Swaminathan S
    Public Health Action; 2017 Jun; 7(2):90-94. PubMed ID: 28695080
    [No Abstract]   [Full Text] [Related]  

  • 55. Variation in attrition at subnational level: review of the Botswana National HIV/AIDS Treatment (Masa) programme data (2002-2013).
    Farahani M; Price N; El-Halabi S; Mlaudzi N; Keapoletswe K; Lebelonyane R; Fetogang EB; Chebani T; Kebaabetswe P; Masupe T; Gabaake K; Auld A; Nkomazana O; Marlink R
    Trop Med Int Health; 2016 Jan; 21(1):18-27. PubMed ID: 26485172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing the costs and effects of antiretroviral therapy task shifting from physicians to other health professionals in ethiopia.
    Johns B; Asfaw E; Wong W; Bekele A; Minior T; Kebede A; Palen J
    J Acquir Immune Defic Syndr; 2014 Apr; 65(4):e140-7. PubMed ID: 24577187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes and factors affecting mortality and successful tracing among patients lost to follow-up from antiretroviral therapy in Pawi Hospital, Northwest Ethiopia.
    Assemie MA; Leshargie CT; Petrucka P
    Trop Med Health; 2019; 47():52. PubMed ID: 31719791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Level of Attrition from Antiretroviral Therapy Among Human Immune Deficiency Virus-Infected Children: The Cases of Sidama Zone, Southern Ethiopia.
    Sifr Z; Ando T; Semeon W; Rike M; Ashami K
    HIV AIDS (Auckl); 2021; 13():813-822. PubMed ID: 34413684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lost to follow up from chronic care services during COVID-19 from health facilities, in Northwest Ethiopia.
    Belay DG; Adugna A
    Front Epidemiol; 2022; 2():883316. PubMed ID: 38455279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistent High Burden and Mortality Associated With Advanced HIV Disease in Rural Tanzania Despite Uptake of World Health Organization "Test and Treat" Guidelines.
    Stöger L; Katende A; Mapesi H; Kalinjuma AV; van Essen L; Klimkait T; Battegay M; Weisser M; Letang E
    Open Forum Infect Dis; 2022 Dec; 9(12):ofac611. PubMed ID: 36540386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.